Expression of MHC class II molecules on human monocytes is regulated independently from each other after phagocytosis of bacteria

Scandinavian Journal of Immunology

Volumn 43, Issue 1, 1996, Pages 39-46

  Wuorela, M ^a,b   Jalkanen, S ^a,b   Toivanen, P ^b   Granfors, K ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ANTIGEN PRESENTATION; ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MONOCYTE; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; YERSINIA ENTEROCOLITICA;

EID: 0030027141     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-3.x     Document Type: Article

References (38)

1. Kingsley G, Panayi G, Antigenic responses in reactive arthritis. Rheum Dis Clin North Am 1992;18:49-6.
2. Hassell AB, Pilling D, Reynolds D, Life PF, Bacon A, Gaston JS. MHC restriction of synovial fluid lymphocyte responses to the triggering organism in reactive arthritis. Absence of a class I-restricted response. Clin Exp Immunol 1992;88:442-7.
3. Life PF, Viner NJ, Bacon PA, Gaston JS. Synovial fluid antigen-presenting cells unmask peripheral blood T cell responses to bacterial antigens in inflammatory arthritis. Clin Exp Immunol 1990;79:189-94.
4. Granfors K, Jalkanen S, von Essen R et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989;320:216-21.
5. Granfors K, Jalkanen S, Lindberg AA et al. Salmonella lipopolysaccharide in synovial fluid cells from patients with reactive arthritis. Lancet 1990;335:685-8.
6. Granfors K. Do bacterial antigens cause reactive arthritis? Rheum Dis Clin North Am 1992;18:37-48.
7. Gemski P, Lazere J, Casey T. Plasmid associated with pathogenicity and calcium dependence of Yersinia enterocolitica. Infect Immun 1980;27:682 5.
8. Laird W, Cavanaugh D. Correlation of autoagglutination and virulence of Yersiniaie. J Clin Microbiol 1980;11:430-2.
9. Ståhlberg TH, Granfors K, Toivanen A. Human antibody response to individual chromosome- and plasmid-encoded antigens of Yersinia enterorolitica O:3. J Infect Dis 1987;156:290-5.
10. Westphal 0, Lüderitz 0, Bister F. Über die Extraction von Bakterien mit Phenol/Wasser. Z Naturforschg 1952;7b:148-55.
11. Hurvell B. Serological cross-reactions between different Brucella species and Yersinia enterocolitica. Acta Path Microbiol Scand Sect C 1973;81:105-12.
12. Pekkola-Heino K, Viljanen MK, Stahlberg TH. Granfors K, Toivanen A. Monoclonal antibodies reacting selectively with core and O-polysaccharide of Yersinia enterocolitica O:3 lipopolysaccharide. Acta Path Microbiol Immunol Scand Sect C 1987;95:27-34.
13. Wuorela M, Jalkanen S, Toivanen P, Granfors K. Yersinia lipopolysaccharide is modified by human monocytes. Infect Immun 1993;61:5261-70.
14. Leino R, Vuento R, Koskimies S, Viander M, Toivanen A. Depressed lymphocyte transformation by Yersinia and Escherichia coli in Yersinia arthritis. Ann Rheum Dis 1983;42:176-81.
15. Inman RD, Chiu B, Johnston ME, Vas S, Falk J. HLA class I-related impairment in IL-2 production and lymphocyte response to microbial antigens in reactive arthritis. J Immunol 1989;142:4256 60.
16. Lahesmaa R, Yssel H, Batsford S et al. Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J Immunol 1992;148:3079-85.
17. Vuento R, Leino R, Viander M, Toivanen A. In vitro lymphoproliferative response to Yersinia: depressed response in arthritic patients years after Yersinia infection. Clin Exp Rheumatol 1983;1:219-24.
18. Blumenthal EJ, Roberts WK, Vasil A, Talmage DW. Macrophage activation: Dissociation of cytotoxic activity from Ia-A antigen expression. Proc Natl Acad Sci USA 1983;80:2031-5.
19. Geppert TD, Lipsky PE. Antigen presentation by interferon-gamma treated endothelial cells and fibroblasts: Differential ability to function as antigen-presenting cells despite the comparable Ia expression. J Immunol 1985;135:3750-62.
20. Vuento R, Leino R, Viander M, Toivanen. A. Lymphocyte transformation responses to gram negative bacteria after Yersinia and Salmonella infection: the importance of enterobacterial common antigen for the response. J Rheumatol 1984;11:369-72.
21. Appel SH, Wellhausen SR, Montgomery R, DeWeese RC, Polk HC. Experimental and clinical significance of endotloxin-dependent HLA-DR expression on monocytes. J Surg Res 1989;47:39-44.
22. Volk H-D, Waschke SR, Diezel W, Grunow R, Bachr R, Fiebig H. Decrease of HLA-DR antigen expression by human monocytes during cultivation in absence of exogenous or endogenous interferon-gamma. Immunol Lett 1985;10:103-7.
23. Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ, Involvement of class II MIIC molecules in the LPS-induction of IL-I TNK secretions by human monocytcs. Quantitative differences at the polymorphic level, J Immunol 1989;143:913-22.
24. Yem AW, Parmely MJ, Modulation of Ia-like antigen expression and antigen-presenting activity of human monocytes by endotoxin and zymosan A. J Immunol 1981;127:2245-51.
25. Ziegler HK, Staffileno LK, Wentworth P. Modulation of macrophage Ia-expression by lipopolysaccharide I. Induction of Ia expression in vivo. J Immunol 1984;133:1825-35.
26. de Waal-Malefyt R, Abrams J, Bennett B Figdor CG, de Vries JE. Interleukin 10 (1L-10) inhibits cylokine synthesis by human monocytcs: An autoregulatory role of 11.-10 produced by monocytes. J Exp Med 1991;174:1209-20.
27. Volk H-D, Gruner S, Falck P, von Baehr R. The influence of mterferoti-gamma and various phagocylic stimuli on the expression of MHC-class II antigens on human monocytes - Relation to the generation of reactive oxygen intermediates. Immunol Lett 1986;13:209-14.
28. Gonwa TA, Frost JP, Karr RW, All human monocytes have the capability of expressing HI.A-DQ and IILA-DP molecules upon stimulation with interferon-gamma. J Immunol 1986;137:519-24.
29. Drexler HG, Gicnac SM, Brenner MK, Coustan-Smith E, Janossy G, Hoffbrand AV. Differential expression of MHC class II antigens in chronic B-cell disorders. Clin Exp Immunol 1988;71:217-23.
30. Ono SJ, Bazil V, Sugawara M, Strominger JL. An isotype-specifictrans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP. J Exp Med 1991;173:629-37.
31. Plaeger-Marshall S, Haas A, Clement LT et al. Interferon-induced expression of class Il major histocomputibility antigens in the major histocompatibility complex (MIIC) class II deficiency syndrome. J Clin Immunol 1988;8:285-95.
32. Hermann E, Mayet W-J, Thomssen II et at. HLA-DP restricted Chlamydia trachomatis specific synovial fluid T cell clones in Chlamydia induced Reiter's disease. J Rheumatlol 1992; 19:1243-6.
33. Ottenhoff THM, Elferink DK, Hermans J, de Vries RRP. HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are asso-ciated with HLA-D/DR and not with DP and DQ. Hum Immunol 1985;13:105-16.
34. Gaschet J, Mahe B, Milpied N et al.Specificity of T cells invading the skin during the acute graft-vs.-host disease after semiallogeneic bone marrow transplantation. J Clin Invest 1993;91:12-20.
35. Salgame P, Convit J, Bloom BR. Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted. Proc Natl Acad Sci USA 1991;88:2598-602.
36. Walters MT, Smith JL, Moore K, Revans P, Cawley MID. An investigation of the action of disease modifying antirheumatic drugs of the rheumatoid synovial membrane: reduction in T lymphocyte subpopulations and HLA-DP and DQ antigen expression after gold and penicillamine therapy. Ann Rheum Dis 1987;46:7-16.
37. Diedriehs M, Schendel DJ. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA. J Immunol 1989;142:3275-80.
38. Caplen HS, Salvadori S, Gansbacher B, Zier KS. Post-transcriptional regulation of MHC class II expression in human T cells. Cell Immunol 1992;139:98-107.